Your browser doesn't support javascript.
loading
Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study.
Li, Yaodong; Chen, Yangxin; Wang, Jingfeng; Xu, Jian; Li, Ruogu; Qiu, Zhaohui; Jiang, Lingyun; Shen, Farong; Jiang, Shubin; Li, Bin; Chu, Yingjie; He, Lang; Pu, Lijin; Han, Xuebin; Long, Xianping; Xue, Xiaolin; Tao, Jianhong; Wu, Yongquan; Guo, Tao; Yuan, Yiqiang; Wang, Xianqing; Wang, Jiang; Xu, Jing; Zhao, Yujie; Zhang, Zhihui; Hua, Wei; Su, Yangang; Tang, Baopeng.
Affiliation
  • Li Y; Department of Cardiovascular Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China (mainland).
  • Chen Y; Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (mainland).
  • Wang J; Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (mainland).
  • Xu J; Department of Cardiology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, China (mainland).
  • Li R; Department of Cardiology, Shanghai Chest Hospital, Shanghai, China (mainland).
  • Qiu Z; Department of Cardiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (mainland).
  • Jiang L; Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China (mainland).
  • Shen F; Department of Cardiology, Zhejiang Qiushi Caridiovascular Hospital, Hangzhou, Zhejiang, China (mainland).
  • Jiang S; Department of Cardiology, The Fourth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China (mainland).
  • Li B; Department of Cardiology, Meizhou People's Hospital, Meizhou, Guangdong, China (mainland).
  • Chu Y; Department of Cardiology, Henan People's Hospital, Zhengzhou, Henan, China (mainland).
  • He L; Department of Cardiology, Zhejiang Greentown Cardiovascular Hospital, Hangzhou, Zhejiang, China (mainland).
  • Pu L; Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China (mainland).
  • Han X; Department of Cardiology, Shanxi Province Cardiovascular Hospital, Taiyuan, Shanxi, China (mainland).
  • Long X; Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China (mainland).
  • Xue X; Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China (mainland).
  • Tao J; Department of Cardiology, Sichuan Provincial People's Hospital, Chengdu, Sichuan, China (mainland).
  • Wu Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China (mainland).
  • Guo T; Department of Cardiology, Fuwai Yunnan Cardiovascular Hospital, Kunming, Yunnan, China (mainland).
  • Yuan Y; Department of Cardiology, Henan Provincial Chest Hospital, Zhengzhou, Henan, China (mainland).
  • Wang X; Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China (mainland).
  • Wang J; Department of Cardiology, Xinqiao Hospital, Chongqing, China (mainland).
  • Xu J; Department of Cardiology, Tianjing Chest Hospital, Tianjin, China (mainland).
  • Zhao Y; Department of Cardiology, Zhengzhou Cardiovascular Hospital, Zhengzhou, Henan, China (mainland).
  • Zhang Z; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China (mainland).
  • Hua W; Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (mainland).
  • Su Y; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China (mainland).
  • Tang B; Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China (mainland).
Med Sci Monit ; 30: e942747, 2024 Feb 24.
Article in En | MEDLINE | ID: mdl-38400538
ABSTRACT
BACKGROUND International studies have shown that use of a subcutaneous implantable cardioverter defibrillator (S-ICD) could reduce lead-related complications while maintaining adequate defibrillation performance; however, data from the Chinese population or other Asian groups are limited. MATERIAL AND METHODS SCOPE is a prospective, multicenter, observational cohort study. Two hundred patients with primary prevention indication for sudden cardiac death (SCD), who are candidates for S-ICD, will be enrolled. From the same population, another 200 patients who are candidates for transvenous implantable cardioverter defibrillator (TV-ICD) will be enrolled after being matched for age, sex, SCD high-risk etiology (ischemic cardiomyopathy, and non-ischemic cardiomyopathy, ion channel disease, and other) and atrial fibrillation in a 1 1 ratio with enrolled S-ICD patients. All the patients will be followed for 18 months under standard of care. RESULTS The primary endpoint is proportion of patients free from inappropriate shock (IAS) at 18 months in the S-ICD group. The lower 95% confidence bound of the proportion will be compared with a performance goal of 90.3%, which was derived from the previous meta-analysis. The comparisons between S-ICD and TV-ICD on IAS, appropriate shock, and complications will be used as secondary endpoints without formal assumptions. CONCLUSIONS This is the first prospective multicenter study focusing on the long-term performance of S-ICD in a Chinese population. By comparing with the data derived from international historical studies and a matched TV-ICD group, data from SCOPE will allow for the assessment of S-ICD in the Chinese population in a contemporary real-world implantation level and programming techniques, which will help us to further modify the device implantation and programming protocol in this specific population in the future.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Defibrillators, Implantable / Cardiomyopathies Limits: Humans Country/Region as subject: Asia Language: En Journal: Med Sci Monit / Med. sci. monit / Medical science monitor Journal subject: MEDICINA Year: 2024 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Defibrillators, Implantable / Cardiomyopathies Limits: Humans Country/Region as subject: Asia Language: En Journal: Med Sci Monit / Med. sci. monit / Medical science monitor Journal subject: MEDICINA Year: 2024 Document type: Article Country of publication: Estados Unidos